Hotline: 1800 102 2007
Hotline: 1800 102 2007
Jan, 10 2018

Hilleman Labs Partners With Future Vaccine Manufacturing Hub

The hub will collaborate with the Developing Countries Vaccine Manufacturing Network on manufacturing projects in India Vietnam Bangladesh Uganda and China

Hilleman Labs Partners With Future Vaccine Manufacturing Hub

Hilleman Laboratories to collaborate with Imperial College London, Engineering and Physical Sciences Research Council (UK) and other premier international bodies towards low-cost vaccine manufacturing.

Hilleman Laboratories, an equal joint-venture partnership between MSD and Welcome Trust, is one of the key partners of the new Future Vaccine Manufacturing Hub led by Imperial College London. The hub has been established to increase immunisation coverage across the globe and improve the response to disease outbreaks through the rapid and cost-effective deployment of vaccines. £10 million of funding has been granted by the UK Department for Health, and will be managed by the Engineering and Physical Sciences Research Council (EPSRC).

Speaking on the occasion, Dr Davinder Gill, CEO Hilleman Laboratories said, “We are honoured to collaborate with Imperial College London and EPSRC in the United Kingdom. We are gratified with this collaboration, which will help us develop our competences through international partnerships. As a partner in manufacturing research projects, we are truly hoping that the new Vaccine Manufacturing Hub will increase immunisation coverage around the globe and respond to disease outbreaks with safe and cost-effective vaccines. It will allow us to invest in innovation more effectively to explore high-quality vaccines & technologies.”

The hub will collaborate with the Developing Countries Vaccine Manufacturing Network on manufacturing projects in India, Vietnam, Bangladesh, Uganda and China. Integrated approaches that will be explored by researchers at the Hub include the development of synthetic RNA vaccines which can be rapidly manufactured; the rapid production of yeast and bacterially-expressed particles that mimic components of pathogenic viruses and bacteria; and protein stabilisation to preserve vaccines at high temperatures, avoiding the need for refrigerated distribution and storage.

sharebtn
Comment
user
email
mobile
address
star
Related opportunities
  • Bricks & Cement & Sand Supplies
    About Us: Ambuja Cements Ltd, a part of the global conglomerate..
    Locations looking for expansion Maharashtra
    Establishment year 1985
    Franchising Launch Date 1985
    Investment size
    Space required 5000
    Franchise Outlets -NA-
    Franchise Type -NA-
    Headquater Mumbai Maharashtra
  • Others Food Service
    About Us: Reasons to Franchise : Popular tea spot in the prime..
    Locations looking for expansion Delhi
    Establishment year 2018
    Franchising Launch Date 2019
    Investment size
    Space required 150
    Franchise Outlets -NA-
    Franchise Type MultiUnit
    Headquater Delhi Delhi
  • Juices / Smoothies / Dairy Parlors
    About Us: Aarkali retails private limited clothing brand for Women is..
    Locations looking for expansion Delhi
    Establishment year 2018
    Franchising Launch Date 2019
    Investment size Rs. 10lac - 20lac
    Space required -NA-
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater New delhi Delhi
  • About Us: Podar Jumbo Kids is the top-most Early Childhood Center..
    Locations looking for expansion Maharastra
    Establishment year 2004
    Franchising Launch Date 2004
    Investment size Rs. 5lac - 10lac
    Space required 1500
    Franchise Outlets -NA-
    Franchise Type Unit
    Headquater MUMBAI Maharastra
Insta-Subscribe to
Entrepreneur
Magazine
sme-80x109
For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you
email
mobile
OR Click here to Subscribe Online
Daily Updates
Submit your email address to receive the latest updates on news & host of opportunities